News

We are pleased to share with you the 2023 OBRI Annual Report which provides an update of our activities over the past year. 2023 OBRI Annual Report (Read more)

The 2024 issue of In the Loop, the OBRI newsletter for participants, is now available on-line. Catch up on our latest research, ongoing projects, and much more. 2024Feb05_OBRI In the Loop (Read more)

This past year, many aspects of our daily lives have changed, including physician visits. We asked a rheumatologist and a patient for their perspectives on making the most of virtual appointments.  The checklist highlights special considerations for both video and … Continue reading → (Read more)

The 2021 issue of the OBRI patient newsletter, In the Loop, is now available online!  Read about our latest research; an arthritis app created by an OBRI investigator; caregiving in times of a pandemic; and much more. In the Loop, … Continue reading → (Read more)

We are pleased to share our latest research findings with you: Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative. Clin Exp Rheumatol. 2023 Jun 15. Impact of the COVID-19 … Continue reading → (Read more)

 The Annual OBRI Conference will take place virtually on Friday, May 8, 2020 from 9-11:30am Due to the current COVID-19 restrictions regarding large group meetings, the OBRI is restructuring the 7th Annual OBRI Conference on Friday, May 8, 2020.  The … Continue reading → (Read more)

Please be advised that in response to COVID-19, UHN has suspended all non-essential on-site research activities until April 6, 2020.  Until further notice, the OBRI team will be working from home.  We will continue to be accessible by email at … Continue reading → (Read more)

The OBRI is excited to share our latest publications: Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada. Supplementary material. Late-onset rheumatoid arthritis has a similar time to remission … Continue reading → (Read more)

OBRI is honoured to be included in the scientific program at the 2019 Annual European Congress of Rheumatology in Madrid, Spain (June 12-15, 2019).  The following scientific posters will be presented in Madrid: Development of an Algorithm for the Classification … Continue reading → (Read more)

On International Women’s Day on March 7, 2019, Dr. Claire Bombardier (OBRI principal investigator) was recognized by The Arthritis Society (TAS) as one of Canada’s Leading Women in Arthritis research. Dr. Bombardier is the inaugural recipient of a lifetime achievement … Continue reading → (Read more)